FDA-approved GLP-1 pill offers cheaper, needle-free option for weight loss
KENT COUNTY, Mich. — A new oral version of the weight loss drug Wegovy has been approved by…
Novo Nordisk plans Wegovy vials amid obesity-drug competition
Novo Nordisk plans Wegovy vials amid obesity-drug competition Proactive uses images sourced from Shutterstock Novo Nordisk (NYSE:NVO) announced…
California is ending coverage for weight loss drugs, despite TrumpRx
SACRAMENTO — Many low-income Californians prescribed wildly popular weight-loss drugs will lose their coverage for the medications in the new…
Weight-loss drugs are changing. Here’s what to know about GLP-1s
Weight-loss drugs known as GLP-1s are transforming health care. Some people who struggled for years to shed pounds…
Doctors warn major changes coming for weight loss drugs in Mass.
Patients and doctors are bracing as some major insurers get ready to roll out changes to coverage for…
Mounjaro mounts to top spot in Indian drug market; Oct sales touch ₹100 cr, ETPharma
New Delhi: Maintaining its growth momentum for the seventh straight month, Eli Lilly’s type-2 diabetes and weight-loss drug…
Warning after ‘King Kong’ of weight-loss jabs found being sold illegally on social media
Fake versions of highly sought-after weight-loss jabs are being sold illegally on social media, an investigation has found.…
Ozempic coming soon to India: What is it? Benefits, side effects and controversies
India’s drug controller, the Central Drugs Standard Control Organisation (CDSCO), approved Ozempic (semaglutide) on 26 September for use…
Research finds half of Ozempic patients quit within a year
Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new…
How the ‘Ozempic effect’ is reshaping the global economy
Michael Siluk/Alamy The new wave of weight-loss drugs has taken the world by storm. From Novo Nordisk’s Ozempic…
Will you take Wegovy to lose weight?
Wegovy is now available in Singapore more than two years after it was approved by the Health Sciences…
As a reporter, I’ve covered all things GLP-1. Here’s what I’ve learned.
I have to admit: When I was assigned to write my first story about the blockbuster weight loss…